ProJenX

0 followers


ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.

Employees

1-10

Links

Org chart

Stan Abel
President and Chief Executive Officer

Stan Abel

Collapse
Emily R. Lowry, Ph.D.
Scientific Co-Founder and Senior Scientific Advisor

Teams

This company has no teams yet